Insmed (INSM) PT Raised to $40 at BofA Securities
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $98.61 +2.93%
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
BofA Securities analyst Jason Zemansky raised the price target on Insmed (NASDAQ: INSM) to $40.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $160 at Evercore ISI
- Plexus (PLXS) PT Raised to $330 at Stifel
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
